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Abstract
The enterococcal community from feces of seven dogs treated with antibiotics for 2–9 days in the veterinary intensive care
unit (ICU) was characterized. Both, culture-based approach and culture-independent 16S rDNA amplicon 454
pyrosequencing, revealed an abnormally large enterococcal community: 1.460.8610
8 CFU gram
21 of feces and
48.9611.5% of the total 16,228 sequences, respectively. The diversity of the overall microbial community was very low
which likely reflects a high selective antibiotic pressure. The enterococcal diversity based on 210 isolates was also low as
represented by Enterococcus faecium (54.6%) and Enterococcus faecalis (45.4%). E. faecium was frequently resistant to
enrofloxacin (97.3%), ampicillin (96.5%), tetracycline (84.1%), doxycycline (60.2%), erythromycin (53.1%), gentamicin (48.7%),
streptomycin (42.5%), and nitrofurantoin (26.5%). In E. faecalis, resistance was common to tetracycline (59.6%), erythromycin
(56.4%), doxycycline (53.2%), and enrofloxacin (31.9%). No resistance was detected to vancomycin, tigecycline, linezolid, and
quinupristin/dalfopristin in either species. Many isolates carried virulence traits including gelatinase, aggregation substance,
cytolysin, and enterococcal surface protein. All E. faecalis strains were biofilm formers in vitro and this phenotype correlated
with the presence of gelE and/or esp. In vitro intra-species conjugation assays demonstrated that E. faecium were capable of
transferring tetracycline, doxycycline, streptomycin, gentamicin, and erythromycin resistance traits to human clinical strains.
Multi-locus variable number tandem repeat analysis (MLVA) and pulsed-field gel electrophoresis (PFGE) of E. faecium strains
showed very low genotypic diversity. Interestingly, three E. faecium clones were shared among four dogs suggesting their
nosocomial origin. Furthermore, multi-locus sequence typing (MLST) of nine representative MLVA types revealed that six
sequence types (STs) originating from five dogs were identical or closely related to STs of human clinical isolates and
isolates from hospital outbreaks. It is recommended to restrict close physical contact between pets released from the ICU
and their owners to avoid potential health risks.
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Introduction
National and international surveillance programs on antimicro-
bial resistance such as SENTRY, SCOPE, SWEDRES, SVARM,
FAO, DANMAP, and NARMS have been established for people
as well as food animals in many parts of the world. Although
recommended, pet animals are typically not included in such
programs [1,2]. According to the American Veterinary Medical
Association, there are about 72 million dogs and 81 million cats in
American households (http://www.avma.org). Unfortunately, no
comprehensive data are available on consumption of antimicro-
bials in small animal veterinary practices in the USA. In recent
past, pet animals have been considered as a putative reservoir of
antimicrobial resistant bacteria based on sporadic cases showing
transmission of pathogenic bacterial strains such as Staphylococcus
aureus [3], S. intermedius [4], S. pseudintermedius [5], Campylobacter jejuni
[6], and Enterococcus faecium [7] between pets and owners.
Furthermore, shedding of high concentrations of Clostridium
perfringens, E. faecalis and E. faecium in feces of dogs with diarrhea
was reported by Bell et al. [8]. The Centers for Disease Control
and Prevention has stated that immunocompromised groups and
children may be at risk for infections with canine zoonotic agents
(www.cdc.gov/healthypets/animals/dogs.html).
Enterococci, ubiquitous in nature and a common commensal of
the intestinal microbiota of people and animals [9], have emerged
as pathogens that rank third among nosocomial infections due to
their resistance to antibiotics, putative virulence traits, and their
biofilm forming capacity [10,11]. The threat posed by enterococci
is magnified due to their ability to horizontally transfer antibiotic
resistance and virulence determinants to other bacteria [12,13].
Only a very few studies addressed the enterococcal population in
pets and all of these focused on healthy animals. In Europe,
Damborg et al. [14,15] reported wide occurrence of human
hospital-associated enterococcal clones among dogs. In the USA,
only one research group examined the dogs and cats as a potential
source of antibiotic resistant enterococci [16]. In the subsequent
study, they also determined the mechanism of antibiotic resistance
and assessed the clonality of the isolates [17]. However,
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mostly neglected from the perspective of studying antibiotic
resistant microbiota, nosocomial strains, and potential animal and
public health implications. Within the hospital environment,
intensive care unit (ICU) provides the most ambient condition for
survival of enterococci as they can withstand an extensive use of
antibiotics and disinfectants [18,19,20].
We hypothesized that companion animals (dogs) treated with
antibiotics in the ICU become a reservoir of antibiotic resistant
and potentially virulent enterococcal population and the corre-
sponding resistance traits are horizontally transferrable. The goal
of this study was to characterize enterococci isolated from the feces
of dogs from the ICU in order to evaluate their potential for
nosocomial and zoonotic infections. In addition, we assessed the
diversity of the overall fecal bacterial community of these dogs by
16S rRNA gene-based 454 pyrosequencing.
Methods
Ethics statement
The ethics permit from the Institutional Review Board was not
required. Collection of canine fecal samples did not involve any
direct contact with animals. The human blood for hemolysis
detection was purchased directly from Rockland Immunochem-
icals Inc. (Gilberstville, PA) and was used based on manufacturer’s
instructions.
Sample collection, isolation, and identification of
enterococci
During 2008–09, over a period of four months, fresh feces of
seven dogs were sampled after a stay at the ICU of the Veterinary
Medicine Teaching Hospital (Kansas State University) for 2–9
days on an antibiotic treatment. Disease history and treatments of
the dogs in the ICU are shown in Table S1. One gram of feces was
resuspended in 10 ml of phosphate buffered saline and up to 30
presumptive enterococcal colonies were randomly selected from
each sample following the standard protocol [21]. The concen-
tration of enterococci was calculated in CFU g
21 of feces and the
isolates were identified to the genus and species levels following
methods described previously [21].
Assessment of the overall fecal bacterial diversity by 454
pyrosequencing
Total genomic DNA was extracted from the same fecal samples
(0.5 g) as above using FastDNAH SPIN kit for soil (MP
Biomedicals) following manufacturer’s instructions. The bacterial
tag-encoded FLX 16S rDNA amplicon parallel pyrosequencing
and post sequencing processing were carried out at the Medical
Biofilm Research Institute (Lubbock, TX) as described by Dowd et
al. [22] and Middelbos et al. [23]. Data were analyzed and
interpreted using Sequencher 4.8 (Gene Codes) for alignment and
sequence editing, MOTHUR [24] for diversity and richness, and
Blast2GO for the NCBI GenBank search.
Antibiotic susceptibility testing and transfer of antibiotic
resistance traits
Antibiotic sensitivity was determined by the disc diffusion
method on Mueller-Hinton agar (Difco) using 10 different
antibiotics (mg disc
21): ampicillin (10), tetracycline (30), doxycy-
cline (30), gentamicin (120), erythromycin (15), enrofloxacin (5),
vancomycin (30), quinupristin/dalfopristin (15), nitrofurantoin
(300), and tigecycline (15). Resistance to streptomycin
(2,000 mgm l
21) and linezolid (8 mgm l
21) was assessed by agar
dilution technique on brain heart infusion (BHI) (BBL) agar.
Minimum inhibitory concentration (MIC, mgm l
21) was deter-
mined for a subset of E. faecium strains (resistant to 4–6 antibiotics
and further used for conjugation assays) by broth microdilution
technique using Mueller-Hinton broth (BBL). The results were
interpreted according to the guidelines of the Clinical and
Laboratory Standards Institute [25,26]. Routine quality control
of antibiotic discs was performed using control strains of E. faecalis
ATCC 19433 and E. faecium ATCC 19434. Multi-drug resistance
was defined as resistance to three or more antibiotics, regardless of
class.
Broth and filter mating experiments were carried out as
described by Ike et al. [27] and Tendolkar et al. [28], respectively,
to study the mobility of seven antibiotic resistance traits from
multi-drug resistant E. faecium strains (6–8 isolates for each trait) to
E. faecium clinical strains. The recipients included the following
strains with appropriate markers: TX5034 (spectinomycin,
MIC=250 mgm l
21) [29] for tetracycline and doxycycline;
TX1330 (rifampicin, MIC=24 mgm l
21) [30] for ampicillin;
ATCC 51559 (rifampicin, MIC=24 mgm l
21) [31] for strepto-
mycin and enrofloxacin; 45–24 (linezolid, MIC=8 mgm l
21) [32]
for erythromycin; and 38–42 (linezolid, MIC=8 mgm l
21) [32] for
gentamicin. Both assays were performed with a donor and
recipient ratio of 1:10. After allowing mating for 4 h in broth
and 16 h on filter, the mixed culture was dilution plated on to BHI
agar supplemented with suitable combinations of antibiotics and
incubated for 24–48 h at 37uC. The transfer frequency for each
isolate was calculated as the number of transconjugants per donor
CFU. The transconjugants were examined for the phenotypic
expression of the resistance traits by determination of MICs as
mentioned above.
Genotypic and phenotypic characterization of virulence
traits
Multiplex PCR was performed to screen the identified isolates
for four putative virulence determinants: gelE (gelatinase), cylA
(cytolysin), asa1 (aggregation substance), and esp (enterococcal
surface protein) [33]. These isolates were also tested for gelatinase
(protease) activity on Todd Hewitt agar (BBL) with 1.5% skim
milk, expression of the asa1 gene (only in E. faecalis) using clumping
assay, and cytolysin expression by b-hemolysis on Columbia blood
agar base (Difco) with 5.0% human blood (Rockland Immuno-
chemicals) as described previously [34].
Biofilm assay on polystyrene microtiter plates
Strains were inoculated in M17 broth (Oxoid) in polystyrene
round-bottomed 96 well plates (Corning) for bacterial growth and
biofilm formation as described previously [35]. Biofilm was
quantified using crystal violet staining method as described by
Hancock and Perego [36]. E. faecalis V583 was used as the positive
control.
Genotyping by multi-locus variable number tandem
repeat analysis (MLVA)
MLVA typing was used to assess the clonality of all 112 multi-
drug resistant E. faecium (with exception of one isolate from dog
ICU-6 that was not viable) according to the protocol described by
Top et al. [37], with the following modifications. In all cases,
template DNA was obtained from freshly boiled cells in distilled
water and the initial denaturation was 94uC for 4 min. For
amplification of VNTR-2, reaction was carried out in 25 ml with
0.2 mM MgCl2 at an annealing temperature of 65uC. MLVA
profiles were submitted to the MLVA database (http://www.
Enterococci and Companion Animals from ICU
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(MT). Clustering of MTs was performed using the eBURST ver. 3
algorithm implemented as a Java applet at http://eburst.mlst.net
described by Feil et al. [38]. eBURST clustering displayed all MTs
from a large MLVA database in a single diagram as a snapshot of
E. faecium clonal diversity and the MTs were further described as
single/double/triple-locus variants (SLVs, DLVs, TLVs).
Genotyping by pulsed-field gel electrophoresis (PFGE)
In order to confirm the MLVA clustering a subset of 49 E.
faecium was typed by PFGE following the protocol of Amachawadi
et al. [39] with minor modifications. Agarose plugs were restriction
digested with 40 U of ApaI (Promega) for 4 h at 37uC. The
digested plugs were run on to a 1.0% SeaKem Gold Agarose
(Lonza) gel using CHEF Mapper (Bio-Rad) with initial pulse time
for 1 s and final time for 20 s at 200 V for 21 h. Cluster analysis
was performed with BioNumerics (Applied Maths) by using the
band-based Dice correlation coefficient and the unweighted pair
group mathematical average algorithm (UPGMA). E. faecium
ATCC 19434 was used as the reference strain.
Genotyping by multi-locus sequence typing (MLST)
One representative of each of nine MTs of E. faecium was typed
using MLST. Seven loci were PCR amplified according to the
standard protocol (http://efaecium.mlst.net/misc/info.asp) using
Maxima Hot Start PCR Master Mix (Fermentas Inc.). PCR
products were purified using DNA Clean and Concentrator kit
(Zymo Research Corp.). Both strands were sequenced by Applied
Biosystems 3730 DNA Analyzer using the same primers.
Sequences were edited, aligned and compared to the reference
set of alleles using CodonCode Aligner ver. 2.0.4. MLST profiles
were submitted to the MLST database (http://efaecium.mlst.net)
and assigned their MLST type (ST). eBURST clustering was
performed as described above using the entire E. faecium MLST
database.
Results
Overall bacterial diversity and enterococcal
concentration in feces of the ICU dogs
Dogs in this study were of diverse breeds covering small to large
size and a broad age group from 2 months to 14 year old (Table
S1). In the ICU, they were treated for various diseases with
antibiotics including b-lactams, tetracycline, fluoroquinolone, and
a third generation cephalosporin (Table S1).
The overall fecal bacterial diversity on the phylum level based
on pyrosequencing results is shown in Figure 1A. Firmicutes
represented the dominant (76.0–98.9%) phylum in 5 out of 7 dogs,
followed by Fusobacteria in the dog ICU-5 (91.1%). Dog ICU-7 had
relatively even distribution among Firmicutes (33.7%), Proteobacteria
(47.7%), and Bacteroidetes (18.5%). Proteobacteria constituted rela-
tively large portion of the bacterial community in two dogs (16.5%
in ICU-6 and 47.7% in ICU-7). Members of the Bacteroidetes
phylum were detected in the dogs ICU-5 (6.1%) and ICU-7
(18.5%). Presence of Actinobacteria was rare with the exception of
dog ICU-6 (7.3%) (Figure 1A).
On the genus level, 17 different genera were detected (cut off:
$1.0% of all sequences per sample) (Figure 1B). Five out of 7 dogs
had abnormally high population of enterococci (range: 17.6–
83.4%). Lactobacillus was dominant (60.269.7%) in the dogs ICU-1
and ICU-4; Fusobacterium was very high (91.1%) in the 2 month old
puppy ICU-5. Genera including Clostridium, Dorea, Roseburia,
Ruminococcus, and Megamonas were detectable in most samples.
Members of Enterobacteriaceae (Escherichia, Shigella) were found in
three dogs (ICU-4, 6 and 7) while Moraxellacaea (Psychrobacter and
Acinetobacter) was abundant only in the dog ICU-5 (Figure 1B).
Bacterial species richness in the canine feces derived from
2,3186170 bp good quality sequences per sample is depicted in
Table S2. Overall, at the distance of 0.03 (species level), 52.468.9
operational taxonomic units (OTU) were detected with the
Shannon diversity index (H9) 1.660.3. The non-parametric
estimators Chao1 and ACE (abundance-based coverage estimator)
project a range of 61.6611.9 to 68.5613.4 OTUs at the 0.03
distance level. The corresponding rarefaction values (Rf) ranged
from 18.2 to 85.9 at the species level (Table S2). Table S3
illustrates in details the bacterial diversity at the rank of species.
Culture-dependent technique confirmed that the enterococcal
concentration in all samples was very high with a mean of
1.460.8610
8 CFU g
21 feces. On the other hand, the enterococ-
cal community was comprised of only two species E. faecalis and E.
faecium, and 3 out of 7 dogs carried only one species (Table 1).
Antibiotic susceptibility and intra-species conjugal
transfer of antibiotic resistance traits
All isolates were screened for their susceptibility to 12 antibiotics
representing 10 classes. The choice of antibiotics was primarily
based on the drugs commonly used to treat human enterococcal
infections and also frequently used in veterinary medicine. E.
faecium was very frequently (43.4%) multi-drug (6–8 antibiotics)
resistant with the most common (22.1%) resistance combination of
ampicillin, tetracycline, doxycycline, gentamicin, erythromycin,
and enrofloxacin (Table S4). The majority (.80%) of E. faecium
showed resistance to wide spectrum of antibiotics including
fluoroquinolone (enrofloxacin: 97.3%), b-lactam (ampicillin:
96.5%), and tetracyclines (tetracycline: 84.1%; doxycycline:
60.2%), followed by resistance to macrolide (erythromycin:
53.1%), aminoglycosides (gentamicin: 48.7%; streptomycin:
42.5%), and nitrofurantoin (26.5%) (Figure 2). The MICs
determined for a subset of multi-drug resistant E. faecium was high
and in the MIC range of human clinical E. faecium isolates
(Table 2). In addition, a considerable number of E. faecalis (44.8%)
was multi-drug (3–4 antibiotics) resistant with tetracycline, doxy-
cycline, and erythromycin or enrofloxacin as the most common
combinations (Table S4). These strains were frequently resistant to
tetracycline (59.6%), erythromycin (56.4%), doxycycline (53.2%),
and enrofloxacin (31.9%) (Figure 2). The antibiotic resistance
profile for each isolate from individual ICU dogs is presented in
Table S5.
The multi-drug resistant E. faecium strains were further
examined for the potential of horizontal gene transfer by broth
and filter conjugation assays. All E. faecium isolates tested
transferred traits conferring resistance to tetracycline and
doxycycline to a clinical strain of E. faecium in broth as well as
filter mating with a transfer rate of 10
24 to 10
25 transconjugants
per donor (T/D) (Table 2). For streptomycin resistance,
transconjugants were obtained only in filter mating with a low
rate of 10
27 T/D. On the other hand, the gentamicin resistance
trait was transferred at a high frequency (10
23 T/D) from 3 out of
6 isolates in broth mating and 5 out 6 isolates in filter mating
(Table 2). The transferability of erythromycin resistance was
higher in filter mating (10
25 T/D) where transconjugants were
obtained from all six isolates in contrast to broth mating where
only 1 out of 6 isolates could transfer the trait with a lower transfer
rate (10
27 T/D). None of the tested isolates transferred ampicillin
and enrofloxacin resistance traits. The transconjugants obtained
were phenotypically confirmed by comparing their MICs for
appropriate antibiotics with respect to that of the donor and
recipient strains (Table 2). The conjugation results were further
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gants, donors and recipients were compared (data not shown).
Virulence factors and biofilm formation
In E. faecalis, the gelE gene was detected frequently (73/94,
77.6%) and 89.0% (65/73) of those with gelE showed strong
gelatinase activity while the rest were weakly gelatinolytic
(Figures 3A and B). In contrast, although E. faecium also commonly
carried gelE (97/113, 85.8%), the majority of these (90/97, 92.7%)
exhibited only weak gelatinase activity (Figures 3A and B). The
enterococcal surface protein gene (esp) was detected in E. faecalis
(34/94, 36.2%) only (Figure 3B). None of the E. faecalis was
positive for the aggregation substance by phenotype (clumping
assay) although 27.6% (26/94) of them carried asa1. The cylA gene
was detected in E. faecalis (21/94, 22.3%) and most of these strains
were b-hemolytic on human blood. In contrast, none of the E.
faecium positive for cylA (42/113, 37.2%) was b-hemolytic
(Figures 3A and B). The virulence genotypic profile for each
ICU dog isolate is illustrated in Table S5.
All E. faecalis isolates tested were biofilm formers (OD595.0.2)
and many of them (47/90, 52.2%) produced a strong biofilm
(OD595.0.7) (Figure 4A). Overall, biofilm formation correlated
with the presence of strong gelatinase phenotype and/or with the
esp gene. In contrast, none of E. faecium formed biofilm and all of
them lacked the strong gelatinase phenotype as well as esp
(Figure 4B).
Clonal analysis and relatedness of E. faecium
Clonal analysis based on MLVA assigned 109 E. faecium isolates
(3 strains from dog ICU-4 were not typeable) to nine MTs
including four novel ones (MTs 335, 336, 337 and 338) (Figure 5).
The population snapshot of the entire E. faecium MLVA database
generated by eBURST offered a view of all major and minor
clonal complexes and indicated MT-1 corresponding to the clonal
complex involved in hospital acquired infections (CC-1) as the
primary founder (Figure 5). MTs 10 and 12 (SLVs of MT-1) were
directly related to MT-1 and included isolates from hospital
outbreaks, clinical infections, and also from hospital and commu-
nity surveys (http://www.umcutrecht.nl/subsite/MLVA/). An-
other three MTs: MT-27 (TLV of MT-1, and DLV of MT-12),
MT-30 (TLV of MT-1, DLV of MT-10, and SLV of MT-27), and
MT-338 (DLV of MT-27 and MT-30) clustered together and were
closely related to isolates from clinical infections and hospital
environment. MT-337 (DLV of MT-30, and SLV of MT-27)
grouped with human clinical isolates along with isolates from
various animals including ostrich, chicken, dog, and pig. MT-336
(4-locus variant of MT-1) distantly placed as an individual MT not
linked to any other MT in the database whereas MT-335 (differed
in all 6 loci from MT-1 and it was TLV of MT-336) was on the
same branch with calf isolates (MTs 64, 66, 67, 69 and 70)
(Figure 5). Interestingly, none of the MTs from our ICU dogs
except MT-337 showed close association with the MTs described
previously from dogs (MTs 53, 60 and 124) (http://www.
umcutrecht.nl/subsite/MLVA/).
Clonality assessment based on PFGE and its correlation to
MLVA is shown in Figure 6. Dogs ICU-3 and ICU-5 were
monoclonal whereas dogs ICU-6 and ICU-7 had only two clonal
populations. Dog ICU-2 was the oldest one and harbored the most
diverse enterococcal population with 5 MTs corresponding to 5
pulsotypes. In dog ICU-4, only one of five isolates was viable and
typed. Interestingly, three identical MTs (MTs 1, 10 and 27) were
shared among dogs ICU-2, ICU-3, ICU-4, and ICU-7 and this
was supported by PFGE clustering as well. Overall, PFGE
dendrogram based on a subset population (49 isolates) of E.
faecium representing different MTs established high concordance
between MLVA and PFGE clusters. However, PFGE was more
discriminatory and resolved 8 subtypes (with .92% similarity)
within four different MTs (Figure 6).
Furthermore, one representative isolate of each MLVA type was
genotyped by MLST. A total of eight different STs were found,
Figure 1. Fecal bacterial diversity in ICU dogs. Diversity based on 16S rDNA amplicon 454 pyrosequencing at (A) phylum level; and (B) genus
level (numbers=% prevalence; Others=genera contributing ,1% of the total population). ICU=intensive care unit.
doi:10.1371/journal.pone.0022451.g001
Table 1. Enterococcal concentration and species diversity in
the feces of dogs from the intensive care unit (ICU).
Sample ID.
Concentration
(CFU g
21) Diversity [n* (%)]
E. faecalis E. faecium
ICU-1 8.3610
4 30 (100) 0
ICU-2 2.2610
8 10 (34.4) 20
# (65.5)
ICU-3 1.2610
8 12 (40.0) 18 (60.0)
ICU-4 1.4610
8 25 (83.3) 5
# (16.7)
ICU-5 4.6610
5 03 0
# (100)
ICU-6 5.8610
7 0 30 (100)
ICU-7 1.3610
8 17 (56.6) 13 (43.4)
*n=number of isolates from each sample.
#one isolate lost during sub-culturing and not analyzed further.
doi:10.1371/journal.pone.0022451.t001
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Six STs (17, 323, 597, 598, 19, and 262) were related to isolates
from clinical infections or hospital outbreaks with ST-17 as the
primary founder (Figure 7). ST-600 placed in the cluster
containing primarily isolates from environment, various animals,
hospital and community surveys (http://efaecium.mlst.net/). ST-
599 was not linked to any other ST in the database. Each ST
represented different MTs obtained from this study (ST-17=MT-
1, ST-19=MT-30, ST-262=MT-10, ST-323=MT-12, ST-
598=MT-27, ST-599=MT-335, and ST-600=MT-336) except
for ST-597 that included MTs 337 and 338 (SLVs to each other).
Discussion
Multi-drug resistant bacteria in human ICUs and resulting
negative impact on treatment outcomes as well as increased
treatment costs have been reported in numerous studies
[18,19,40–42]. In contrast, relatively little is known about
veterinary ICUs in terms of antibiotic resistant strains, animal
nosocomial infections, and potential human health risks [43].
Boerlin et al. [44] highlighted the potential problem of nosocomial
antibiotic resistance in a veterinary teaching hospital when they
examined Acinetobacter baumanii and E. faecium from infected surgical
wounds. Moreover, an increase in the proportion of antibiotic
resistant rectal Escherichia coli was found associated with longer
hospitalization time of dogs [45]. Recently, Clooten et al. [46]
reported Clostridium difficile in 18% of cats and dogs treated
(n=402) in the veterinary ICU. Another recent study provided
new information on antibiotic use in critically ill dogs in the small
animal ICU in the USA, and reported 19 out of 70 isolates
(27.0%) to be multi-drug resistant A. baumanii, E. coli, and
Enterobacter spp. [47]. However, the majority of samples (endotra-
cheal washes, urine, and peritoneal fluid) were taken within first
24 h of hospitalization and that may explain a relatively low
frequency of multi-drug resistant population. Unfortunately, this
study did not focus on the digestive tract microbes and it is
therefore not comparable to ours.
In our study, we characterized enterococci isolated from feces of
dogs that stayed at the veterinary ICU for 2–9 days and received
an antibiotic treatment. In addition, we used the 454 parallel
pyrosequencing approach to assess the overall bacterial diversity in
the same fecal samples.
Overall bacterial diversity
Studies assessing canine fecal or digestive tract microbial
diversity focused only on healthy animals and it has been reported
that irrespective of animal age and breed, major bacterial taxa
included Bacteroidetes, Fusobacteria, lactobacilli and streptococci
(Firmicutes), whereas the enterococcal, clostridial, bifidobacterial,
and eubacterial groups were less prominent [48,49]. Previously,
barcoded pyrosequencing was applied to analyze the fecal
microbiota of healthy dogs and showed that the vast majority
(.99%) belonged to the five phyla that we also detected in our
ICU dogs; however, phyla Sprirochetes and Tenericutes were found
only in healthy animals [23]. Another pyrosequencing based study
reported c-Proteobacteria as the most dominant group in the small
intestine of dogs at pre- and post-tylosin treatment [50]. In
contrast, the abundance of c-Proteobacteria in our study was low
(,16.5% of all sequences) with the exception of the dog ICU-7
where it comprised 47.7%. Members of the phyla Firmicutes and
Actinobacteria are well-known for their ability to withstand harsh
conditions and for their resistance to various antibiotics [51,52].
Here we report remarkably high proportion of Firmicutes in 5 out of
7 dogs (76.0–98.9%) compared to published data on healthy dogs
(in feces: 14–28%, [23]; in the digestive tract: ,40% [51]). This is
likely result of changes in the gut microbiome due to animal
sickness, stress, and antibiotic treatment. However, the actino-
bacterial population in the ICU dogs (1.661.0%) was comparable
to that of healthy dogs (0.8–1.4%) [23]. The phylum Fusobacteria
was represented by the sole genus Fusobacterium in both ICU and
healthy dogs. It is important to keep in mind however, that the
PCR and pyrosequencing approach assessing diversity of complex
microbial communities may introduce some bias towards specific
bacterial taxa due to differences in cell lyses and primer annealing.
The pyrosequencing-based datasets with relatively high number
of reads (range: 2,600–9,300 with a mean of ,4,000 reads per
sample) were unable to fully cover the diversity of the fecal
microbiota of healthy dogs [23]. Despite a relatively low number
of sequences, our dataset (,2,300 reads per sample) indicates the
low microbial diversity and dominance of one to two genera in the
Figure 2. Antibiotic resistance profile of enterococci from the feces of ICU dogs. AM=ampicillin, TET=tetracycline, D=doxycycline,
GM=gentamicin, STR=streptomycin, E=erythromycin, ENO=enrofloxacin, VA=vancomycin, Q/D=quinupristin/dalfopristin, LIN=linezolid,
NF=nitrofurantoin, TGC=tigecycline, ICU=intensive care unit. *not applicable for E. faecalis isolates due to their intrinsic resistance.
doi:10.1371/journal.pone.0022451.g002
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observation obtained from pyrosequencing data was on the genus
level where enterococci made an abnormally high proportion of
the fecal microbiota in 5 out of 7 dogs. Previous culture-dependent
as well as culture-independent studies showed that enterococci
make up less than 1.0% of the intestinal microbiota of healthy dogs
[53] which is typical for the digestive tract microbiota of other
mammals including people [54]. The mean of the enterococcal
community size (48.9611.5%) in the ICU dogs was 50–100 fold
higher when compared to that of the healthy dogs intestinal
microbiota (0.1–0.5%) [51] or even dogs treated with antibiotic
tylosin (1.1%) [52]. Our pyrosequencing results were further
supported by the culture-dependent technique where the entero-
coccal concentration (1.460.8610
8 g
21 feces) in the ICU dogs
was up to 100 fold higher than that (10
3–10
6 CFU g
21 feces)
reported from the healthy canine gut [15]. To our knowledge, this
is the first study reporting such a high enterococcal population in
the digestive tract of diseased dogs irrespective of the class of
antibiotic used. Overall, antibiotic treatments and animal health
condition did not disturb the composition of the microbiota at the
phylum level; however, there was a great variation in the microbial
community among dogs on the genus level.
The resolution of our dataset based on 16S rDNA decreased
beyond the genus level depending on the length of good-quality
sequence and on the specific bacterial taxon, yet a glimpse of species
richness was obtained. It is worrisome to note that Streptococcus
gallolyticus, Salmonella enterica, Shigella boydii and several strains of
Clostridium (C. difficile, C. symbiosum, C. glycolicum, C. baratii, C. sordellii,
C. perfringens) that can have a negative effect on human as well as
animal health [55], were tentatively detected in some of the ICU
dogs though at a relatively low frequency. Therefore, the risk
associated with ill dogs is not limited to shedding high numbers of
antibiotic resistant enterococci as the digestive tract of these animals
may contain other bacteria of public health importance.
The number of OTUs in the feces of our ICU dogs was about
three fold lower than that in the digestive tract [51] and feces [23]
of healthy dogs. Shannon diversity index (H9) in healthy dogs was
almost double of that in the ICU dogs [23,51]. Moreover,
compared to our results, the species richness (OTUs=149) and
diversity (H9=2.84) as well as ACE (209) and Chao1 (204)
estimates were much higher in the study on the canine jejunum
microbiota after tylosin treatment [52]. Nevertheless, rarefaction
values did not reach a plateau and thereby additional sequencing
to assess the diversity in greater depth is warranted.
Culture-based as well as culture-independent studies of the healthy
canine feces revealed a diverseenterococcal community that typically
included E. faecalis, E. faecium, E. hirae, E. avium, E. raffinosus, E. durans,
E.casseliflavus,E.gallinarum,E. mundtii,a n dE. canintestini[16,56–59]. In
contrast, feces of the ICU dogs in our study contained only two
species, E. faecalis and E. faecium,a n dt h r e eo u to f7d o g sh a d
exclusively only one of these. Such reduced diversity further likely
reflects the effect of antibiotictherapy on the enterococcal population.
Antibiotic resistance of enterococci
A number of studies in different parts of Europe demonstrated
reduced susceptibility to several antibiotics including tetracycline,
erythromycin, ampicillin, enrofloxacin, ciprofloxacin, and rifam-
picin among E. faecalis and E. faecium isolated from healthy pets
(dogs and cats) [14,60–62]. Furthermore, enterococcal isolates
from diseased dogs under b-lactam treatment in the UK and
Denmark showed high resistance to ampicillin (100%), erythro-
mycin (97%), ciprofloxacin (92%), tetracycline (89%), rifampin
(54%), followed by low frequency of resistance to gentamicin (5%),
linezolid (3%), and streptogramins (2%) [15]. In a veterinary
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proportion of multi-drug resistant enterococcal urinary tract
infections (UTI) in dogs over a 15 year period was documented
[63]. The only study conducted in the United States included on
an average 1–2 enterococcal isolates from each of 155 dogs and
121 cats representing an overview of the prevalence of antibiotic
resistance in the healthy small animal population [16]. Conse-
quently, the species diversity and actual shedding of resistant
enterococci from individual animals could not be evaluated.
Though multi-drug resistant E. faecalis and E. faecium were detected
in healthy pets, no supportive information was available on the
history of their antibiotic exposure [16]. In our study, a strong
association was found between the antibiotic treatment and
resistant population in two instances where enterococcal isolates
from the dog ICU-1 treated with doxycycline and the dog ICU-5
treated with ampicillin showed 90% and 100% resistance to the
respective antibiotics. The dog ICU-6 received cefpodoxime
treatment and since enterococci are intrinsically resistant to 3
rd
generation cephalosporins, they were not affected directly.
However, cefpodoxime probably greatly affected other bacteria
in the digestive tract of this dog resulting in the major shift towards
enterococci. Fortunately, unlike in Europe [64–66], all fecal
isolates from the ICU dogs were susceptible to vancomycin as well
as drugs for the second-line of treatment including linezolid,
quinupristin/dalfopristin, and tigecycline likely due of their
restricted and judicious use in the USA.
Horizontal transfer of resistance traits of E. faecium
In the last two decades, multi-drug resistant E. faecium has
emerged as a serious nosocomial pathogen in human hospitals
Figure 3. Profiles for virulence traits of enterococci from the feces of ICU dogs. Profiles for (A) gelatinase (protease) and hemolysis
phenotypic assays, and (B) presence of virulence genes. ICU=intensive care unit. *not applicable for E. faecium.
doi:10.1371/journal.pone.0022451.g003
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PLoS ONE | www.plosone.org 7 July 2011 | Volume 6 | Issue 7 | e22451[67]. Ike et al. [27] described intra- as well as inter-species transfer
of the gentamicin resistance trait from E. faecium via a pheromone-
independent conjugal plasmid pMG1 with a transfer frequency of
10
24 per donor cell in broth mating, which is similar to the intra-
species transfer rate (10
23 per donor) in the ICU dog isolates in
both, broth and filter mating, assays. Transfer frequency (10
27–
10
25) for erythromycin resistance among E. faecium in both mating
assays also fell within the range that is typically mediated by
conjugative transposons [68]. In a recent study by Arias et al. [69],
transfer of genes for streptomycin resistance has been demonstrat-
ed with a rate of 10
25 per donor cell in filter mating, which is
higher than that (10
27) determined in our study. The low transfer
rate indicated that this resistance trait may not be carried by high
frequency transferable plasmids carrying other virulence factors
such as hylEfm [69]. Intra-species transfer (10
25 in broth mating
and 10
24 in filter mating) of tetracycline resistance in enterococci
has been shown involving conjugative transposon Tn916 [70],
whereas transfer of resistance to doxycycline has only been
observed in Streptococcus sanguinus via conjugative transposon
CTn6002 (a complex element partly derived from Tn916) [71].
Our data revealed a high transfer rate (10
24–10
25) for both,
tetracycline and doxycycline resistance traits, indicating potential
involvement of Tn916. Ampicillin and enrofloxacin resistance
traits could not be transferred in vitro, possibly because the
conferring resistance genes such as pbp5 or gyrA are commonly
encoded on non-transferable regions of the chromosome [72,73].
This part of the study demonstrated that companion animals
after release from the ICU and on antibiotic treatment harbor a
large multi-drug resistant enterococcal community. Consequently,
the spread of antibiotic resistant strains and resistance traits via the
companion animals is plausible. Transmission of pathogenic
strains of methicillin resistant staphylococci [5,74] and vancomy-
cin resistant enterococci [7,75] between domestic/clinic pets and
people (owners/clinic staff) has been suggested previously.
Virulence traits and biofilm formation
E. faecalis strains are well-known for their association with
endocarditis, bacteremia, and UTIs due, in part, to virulence
factors such as GelE and Esp [76]. Presence of gelE and esp has
been reported to enhance biofilm formation by E. faecalis and E.
faecium and this likely confers a significant survival advantage by
increasing bacterial resistance to stressful environmental condi-
tions and antimicrobial exposure [35,36,77–79]. It is noteworthy
that most of the E. faecalis from the ICU dogs harbored and
expressed either gelE or esp or both and formed biofilm in vitro,
suggesting that these isolates may be opportunistically pathogenic
under suitable conditions. Aggregation substance (AS) along with
enterococcal binding substance (EBS) has been shown to be
associated with E. faecalis mediated endocarditis [80]. Despite the
presence of asa1 (one of the genes encoding AS) in a large portion
of E. faecalis from the ICU dogs, these strains were phenotypically
negative in vitro. It is likely that specific in vivo conditions are
required for the expression of asa1 [81]. Cytolysin is a unique
secreted bacterial toxin hemolytic to human, horse, and rabbit
erythrocytes and it also is bactericidal to other Gram-positive
bacteria [82]. Presence of cylA (one of the genes encoding cytolysin)
in E. faecalis and corresponding b-hemolytic activity may not only
make these strains more pathogenic, but also might facilitate the
competition with other Gram-positive bacteria in the gut. Since
the gut of ICU dogs was overpopulated with enterococci, there
was a high likelihood of triggering quorum sensing that could
activate gelE as well as cylA in vivo [83,84].
In contrast, while many E. faecium also tested positive for gelE
and cylA, none of them were positive for the strong gelatinase
phenotype and b-hemolysis, respectively. Although few other
studies [85,86] reported presence of silent gelE and cylA in E.
faecium, both of these genes are not common in this species [33].
Overall, E. faecalis expressed more virulence traits than E. faecium
possibly reflecting its greater prevalence in enterococcal nosoco-
mial infections [11].
Genotypic diversity
Genetic similarities between multi-drug resistant enterococcal
strains isolated from dogs and humans/hospitalized patients have
been evident from fingerprinting techniques such as AFLP [87],
PFGE [75], and MLST [14,15]. MLVA has also been successfully
introduced for genotyping E. faecium from large nosocomial
outbreaks [88]. MLVA clustering analysis of multi-drug resistant
E. faecium from the ICU dogs portrayed their lineages and the
global epidemiology. Interestingly, only one MT from the ICU
Figure 4. Biofilm formation, gelatinase (protease) phenotype and presence of esp in enterococci from the feces of ICU dogs. (A) E.
faecalis (n=90), (B) E. faecium (n=85). The dashed lines indicate biofilm formation activity (,0.2=no biofilm, 0.2–0.7=biofilm, .0.7=strong biofilm).
Bars correspond to the mean 6 SEM of 5 replicates. E. faecalis V583 used as a positive control.
doi:10.1371/journal.pone.0022451.g004
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seven out of 9 MTs were related to MTs from human clinical
infections and hospital outbreaks. MLVA data supported by
PFGE analysis indicated a low genotypic diversity of E. faecium
likely reflecting the antibiotic selective pressure. Although the
majority of our strains were host specific (unique MTs and
pulsotypes in individual dogs); interestingly, sharing of three E.
faecium clones among four dogs suggested a possible nosocomial
origin of these strains. In contrast, high genotypic diversity of E.
faecium was detected in healthy dogs without antibiotic selective
pressure [17].
Based on MLST analysis, the E. faecium disseminated in human
hospitals in several parts of the world belongs to the clonal
complex 17 (CC-17) containing several sub-complexes [67,89,90].
Cluster analysis based on MLST further confirmed close relation
of E. faecium from the ICU dogs in our study and strains from
human clinical infections and hospital outbreaks. One ST
belonged to the CC-17 (ST-17) and four other clonal types were
directly or indirectly (via sub-complex ST-18) linked to CC-17 as
well. Only one of the clones (a new ST-600) from dog ICU-6
clustered with other isolates from pets. Number of genotypes
generated by MLST and MLVA were in good agreement with one
exception where two different MTs were found to be identical
based on MLST analysis. It has been established that the gradual
accrual of virulence factors (esp, fms, hyl) and resistance genes (for
streptomycin, ampicillin, gentamicin, and vancomycin) resulted in
the formation of the genogroup CC-17 [91,92]. Damborg et al.
[15] demonstrated that canine E. faecium isolates, in spite of the
lack of esp and hyl, were related to hospital associated E. faecium
clones (ST-78 and ST-192). It is interesting to note that E. faecium
from our ICU dogs, though also negative for esp, were resistant to
ampicillin and high concentration aminoglycosides and this
further emphasizes their potential connection to human clinical
clones.
In summary, the dogs after release from the ICU and on an
antibiotic treatment harbored a very large multi-drug resistant
population of E. faecalis and/or E. faecium. The ability to transfer
the resistance traits horizontally, presence of virulence factors as
well as biofilm forming capacity underline the potential clinical
importance of these strains. The diversity of the overall fecal
Figure 5. Clustering of nine E. faecium MTs from the feces of ICU dogs. eBURST clustering of nine multi-locus variable number tandem repeat
analysis types (MTs) representing 109 E. faecium isolates from the present study (indicated by solid line circles), with one representative isolate from
each of 339 MTs available in the MLVA database. Each MT is represented as a node and differs in one VNTR locus. Dotted line circles indicate MTs
from A: clinical infections, hospital outbreaks, hospital and community surveys; B: clinical infections, hospital environment; C: clinical infections,
animals and birds (ostrich, chicken, dog, pig); D: calves and community survey. ICU=intensive care unit.
doi:10.1371/journal.pone.0022451.g005
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E. faecium strains revealed very low clonal diversity, their possible
nosocomial origin, and close relatedness to human clinical isolates.
While the temporal effect of antibiotic treatment on the canine gut
microbial community and its antibiotic resistance profile remains
to be determined, based on results of several studies with human
and mouse microbiota [93–95], it may be long lasting. Prudent use
of antibiotics in veterinary medicine is critical in order to avoid
treatment failures and zoonotic spread of multi-drug resistant
bacterial strains. Importantly, restricted contact between treated
dogs and their owners is recommended to avoid health risks.
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